Document Format Files
Seq | Description | Document | Type | Size |
---|---|---|---|---|
1 | FORM S-1 | d657876ds1.htm | S-1 | 1837572 |
2 | AMENDED AND RESTATED CERTIFICATE OF INCORPORATION, AS AMENDED | d657876dex31.htm | EX-3.1 | 77873 |
3 | BYLAWS, AS CURRENTLY IN EFFECT | d657876dex33.htm | EX-3.3 | 80582 |
4 | AMENDED AND RESTATED INVESTORS' RIGHTS AGREEMENT | d657876dex41.htm | EX-4.1 | 161355 |
5 | 2005 STOCK PLAN, AS AMENDED | d657876dex102.htm | EX-10.2 | 75279 |
6 | FORMS OF NOTICE OF STOCK OPTION GRANT, STOCK OPTION AGREEMENT & EXERCISE NOTICE | d657876dex103.htm | EX-10.3 | 60863 |
7 | FORM OF EXECUTIVE CHANGE IN CONTROL SEVERANCE BENEFITS PLAN | d657876dex107.htm | EX-10.7 | 50536 |
8 | COLLABORATION AND LICENSE AGREEMENT | d657876dex108.htm | EX-10.8 | 910826 |
9 | ADDENDUM NO. 1 TO COLLABORATION AND LICENSE AGREEMENT | d657876dex109.htm | EX-10.9 | 56113 |
10 | MASTER SERVICES AGREEMENT | d657876dex1010.htm | EX-10.10 | 173757 |
11 | LICENSE AGREEMENT | d657876dex1011.htm | EX-10.11 | 43100 |
12 | LEASE BY & BETWEEN ALDER BIOPHARM. INC.& RREEF AMERICAN REIT II CORP. | d657876dex1012.htm | EX-10.12 | 270841 |
13 | 1ST AMENDMENT TO LEASE, ALDER BIOPHARM. AND AND RREEF AMERICAN REIT II CORP. KK | d657876dex1013.htm | EX-10.13 | 44070 |
14 | 2ND AMENDMENT TO LEASE, ALDER BIOPHARM. AND KBS NORTH CREEK, LLC | d657876dex1014.htm | EX-10.14 | 73211 |
15 | 3RD AMENDMENT TO LEASE, ALDER BIOPHARM. AND KBS NORTH CREEK, LLC | d657876dex1015.htm | EX-10.15 | 90414 |
16 | AMENDED & RESTATED OFFER LETTER BY AND BETWEEN ALDER BIOPHARM. & R. SCHATZMAN | d657876dex1016.htm | EX-10.16 | 16688 |
17 | AMENDMENT TO AMENDED & RESTATED OFFER LETTER, ALDER BIOPHARM. & R SCHATZMAN | d657876dex1017.htm | EX-10.17 | 10230 |
18 | AMENDED & RESTATED OFFER LETTER, ALDER BIOPHARM. & J LATHAM | d657876dex1018.htm | EX-10.18 | 16825 |
19 | AMENDMENT TO AMENDED & RESTATED OFFER LETTER, ALDER BIOPHARM. & J LATHAM | d657876dex1019.htm | EX-10.19 | 9851 |
20 | AMENDED & RESTATED OFFER LETTER, ALDER BIOPHARM. & M LITTON | d657876dex1020.htm | EX-10.20 | 16728 |
21 | AMENDMENT TO AMENDED & RESTATED OFFER LETTER, ALDER BIOPHARM. & M LITTON | d657876dex1021.htm | EX-10.21 | 9885 |
22 | AMENDED & RESTATED OFFER LETTER, ALDER BIOPHARM. & J SMITH | d657876dex1022.htm | EX-10.22 | 16847 |
23 | AMENDMENT TO AMD & RESTATED OFFER LETTER, ALDER BIOPHARM. & J SMITH | d657876dex1023.htm | EX-10.23 | 9620 |
24 | SUBSIDIARIES OF ALDER BIOPHARM. | d657876dex211.htm | EX-21.1 | 2017 |
25 | CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. | d657876dex231.htm | EX-23.1 | 1606 |
26 | GRAPHIC | g657876g18j62.jpg | GRAPHIC | 37498 |
27 | GRAPHIC | g657876g31d69.jpg | GRAPHIC | 60902 |
28 | GRAPHIC | g657876g32k28.jpg | GRAPHIC | 33907 |
29 | GRAPHIC | g657876g39f57.jpg | GRAPHIC | 21292 |
30 | GRAPHIC | g657876g42y11.jpg | GRAPHIC | 41962 |
31 | GRAPHIC | g657876g51n96.jpg | GRAPHIC | 59704 |
32 | GRAPHIC | g657876g63z62.jpg | GRAPHIC | 10772 |
33 | GRAPHIC | g657876g68h64.jpg | GRAPHIC | 15210 |
34 | GRAPHIC | g657876g78f28.jpg | GRAPHIC | 29201 |
35 | GRAPHIC | g664176exo_pg33.jpg | GRAPHIC | 101576 |
36 | GRAPHIC | g664176exo_pg34.jpg | GRAPHIC | 127208 |
37 | GRAPHIC | g664176exp_pg07.jpg | GRAPHIC | 188161 |
38 | GRAPHIC | g664176exp_pg08.jpg | GRAPHIC | 123546 |
39 | GRAPHIC | g664176exp_pg09.jpg | GRAPHIC | 136242 |
40 | GRAPHIC | g664176exp_pg10.jpg | GRAPHIC | 132076 |
41 | GRAPHIC | g664176exq_pg06.jpg | GRAPHIC | 130471 |
42 | GRAPHIC | g664176exq_pg07.jpg | GRAPHIC | 145378 |
43 | GRAPHIC | g664176exq_pg08.jpg | GRAPHIC | 183424 |
44 | GRAPHIC | g664176exq_pg17.jpg | GRAPHIC | 174080 |
45 | GRAPHIC | g664176exr_pg19.jpg | GRAPHIC | 112678 |
46 | GRAPHIC | g664176g97r06.jpg | GRAPHIC | 25484 |
Complete submission text file | 0001193125-14-104868.txt | 6725902 |
IRS No.: 000000000 | State of Incorp.: DE
Type: S-1 | Act: 33 | File No.: 333-194672 | Film No.: 14702568
SIC: 2834 Pharmaceutical Preparations